Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

New England Journal of Medicine - Tập 348 Số 8 - Trang 694-701 - 2003
Holcombe E. Grier1, Mark Krailo2, Nancy J. Tarbell3, Michael P. Link4, Christopher Fryer5, Douglas J. Pritchard6, Mark C. Gebhardt7,8, Paul S. Dickman9, Elizabeth J. Perlman10, Paul A. Meyers11, Sarah S. Donaldson12, Sheila Moore13, Aaron R. Rausen14, Teresa J. Vietti15, James S. Miser16
1Departments of Pediatric Hematology and Oncology, Dana–Farber Cancer Institute and Children's Hospital, Boston, Harvard Medical School, Boston
2Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, Harvard Medical School, Boston
3Radiation Oncology, Massachusetts General Hospital, Boston, Harvard Medical School, Boston
4Pediatrics, Harvard Medical School, Boston
5Pediatrics, King Khalid National Hospital, Jeddah, Saudi Arabia
6Mayo Clinic, Rochester, Minn.
7Orthopedic Surgery, Children's Hospital, Boston
8Orthopedic Surgery, Harvard Medical School, Boston
9Pathology, Children's Hospital of Pittsburgh, Pittsburgh
10Pathology, Johns Hopkins Hospital, Baltimore
11Memorial Sloan-Kettering Cancer Center, New York
12Radiation Oncology, Harvard Medical School, Boston
13Keck School of Medicine, University of Southern California, and Radiology, Children's Hospital of Los Angeles — both in Los Angeles
14Pediatrics, New York University Medical Center, New York
15Division of Pediatric Hematology and Oncology, Washington University Medical Center, and Pediatrics, Washington University School of Medicine, St. Louis
16Pediatrics, City of Hope National Medical Center, Duarte, Calif.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.26.3.174

Nesbit ME, 1990, J Clin Oncol, 8, 1664, 10.1200/JCO.1990.8.10.1664

10.1002/1097-0142(197212)30:6<1522::AID-CNCR2820300617>3.0.CO;2-J

10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M

Antman KH, 1989, J Clin Oncol, 7, 126, 10.1200/JCO.1989.7.1.126

10.1007/BF00253239

10.1007/BF00647446

Miser JS, 1987, J Clin Oncol, 5, 1191, 10.1200/JCO.1987.5.8.1191

10.1002/1097-0142(19930301)71:5<1898::AID-CNCR2820710529>3.0.CO;2-Q

Dehner LP, 1994, Arch Pathol Lab Med, 118, 606

10.1016/0165-4608(86)90001-4

10.1016/0165-4608(88)90285-3

10.1038/ng0294-146

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

10.1214/aos/1176350951

Oberlin O, 1992, J Clin Oncol, 10, 1407, 10.1200/JCO.1992.10.9.1407

Meyer WH, 1992, J Clin Oncol, 10, 1737, 10.1200/JCO.1992.10.11.1737

Kushner BH, 1995, J Clin Oncol, 13, 2796, 10.1200/JCO.1995.13.11.2796

10.1002/(SICI)1097-0142(19960815)78:4<901::AID-CNCR30>3.0.CO;2-X

10.1002/(SICI)1097-0142(19980315)82:6<1174::AID-CNCR24>3.0.CO;2-2

Craft A, 1998, J Clin Oncol, 16, 3628, 10.1200/JCO.1998.16.11.3628

10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O

Paulussen M, 2001, J Clin Oncol, 19, 1818, 10.1200/JCO.2001.19.6.1818

Kamen BA, 1995, J Clin Oncol, 13, 307, 10.1200/JCO.1995.13.2.307